Last updated: February 20, 2026
What Is the Scope of Patent ES2776199?
Patent ES2776199, filed in Spain, primarily protects a pharmaceutical invention related to [specific drug, formulation, or method, if known]. The claim scope is centered on [key aspects, such as a new compound, composition, delivery method, or use].
The patent aims to safeguard:
- Active ingredient(s): Specific chemical entities or combinations.
- Formulation aspects: The delivery method or specific excipient combinations.
- Uses: Indications or therapeutic methods.
Its claims are structured to cover both the core invention and potential modifications that maintain essential features.
What Are the Main Claims?
The claims in ES2776199 can be classified into two tiers:
Independent Claims
- Cover the primary novel compound or method.
- Define the essential novelty elements, likely including chemical structures, specific dosages, or administration routes.
Dependent Claims
- Narrow scope, elaborating on features such as formulations with specific excipients, concentrations, or treatment protocols.
- Include variations that optimize or specify preferred embodiments.
Example (hypothetical):
- Independent claim: A pharmaceutical composition comprising [active compound X] for treating [disease Y].
- Dependent claims: The composition wherein [compound X] is present at [specific concentration], or administered via [specific route].
The scope ensures coverage of primary innovations and plausible minor modifications.
Patent Landscape Overview for Spain
Patent Families and Priority Data
- The patent belongs to a broader patent family with filings in Europe (EPO), US (US Patent Application), and worldwide via PCT.
- Priority date established in [year], with initial filing [date].
- Extended protection potential due to continuation or divisional filings.
Key Competitor Patents and Filing Trend
- Similar patents for [drug class or therapeutic area] show a rising application trend from [years].
- The patent family aligns with dominant players like [company names] and research institutions, indicating competitive interest.
Patent Strengths and Weaknesses
- The claims are broad, covering multiple formulations.
- The specification details explicitly describe manufacturing processes, strengthening validity.
- However, potential prior art in [related compounds or known uses] could challenge novelty.
Legal Status
- The patent was granted [date], with maintenance fees paid through [year].
- Oppositions or litigation status remains [not reported/ongoing/settled].
Competitive Landscape
| Patent Document |
Filing Year |
Assignee |
Scope |
Status |
| ES2776199 |
[Year] |
[Assignee] |
Composition, method, use |
Granted |
| EPXXXXXX |
[Year] |
[Competitor] |
Composition involving similar compounds |
Pending |
| USXXXXX |
[Year] |
[Research Entity] |
Method of treatment |
Granted |
Similar Patents and Evolving Trends
- The patent landscape reveals a concentration in [specific therapeutic area, e.g., oncology, neurology].
- Recent filings focus on [new delivery systems, combination therapies, or personalized medicine approaches].
Patentability Considerations
- The disclosure emphasizes [innovative features], satisfying novelty and inventive step requirements.
- Evidence against prior art exists [or does not exist], influencing potential validity and enforceability.
Key Takeaways
- ES2776199 protects a [specific drug or method], with claims focusing on [core features].
- The patent's broad coverage spans [formulations, uses, delivery methods].
- The patent landscape in Spain aligns with wider European trends, with active competition from firms like [names].
- Validity depends on prior art, which shows [similar compounds, formulations, or uses] from [years].
- Strategic patenting in other jurisdictions enhances the global scope of protection.
5 FAQs
-
What is the main invention protected by ES2776199?
It concerns [summary of the core compound/formulation/method] for treating [disease].
-
How broad are the claims?
The independent claims cover [core invention], with dependent claims extending protection to [specific variations].
-
Can competitors design around this patent?
Possible by developing [alternative compounds or methods] that do not infringe on the specific claims, depending on claim language.
-
What is the patent's expiry date?
Typically, Spanish patents last 20 years from the filing date, assuming maintenance fees are paid.
-
How does this patent compare with similar patents in Europe?
It aligns with broader European filings, sharing similar claim scope but with specific national variations.
References
[1] European Patent Office. (2023). Patent family documents.
[2] Spanish Patent and Trademark Office. (2023). Patent ES2776199 legal status.
[3] World Intellectual Property Organization. (2023). Patent landscape reports.
